Stool Sampling in the Acute Isolated Patient , Efficient Acquiring With a Novel Device

January 29, 2026 updated by: Zealand University Hospital

Stool Sampling in the Acute Isolated Patient, Efficient Acquiring With a Novel Device

stool sample device tested on patients admitted to oncological dept. with diarrhea, in order to shorten time in isolation and time to relevant treatment.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

the stool sample device will be tested on all patients admitted to an oncological dept. on Zealand University Hospital, with diarrhea, in order to examine if the the device is feasabel and able to shorten time in isolation and time to relevant treatment.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Denmark
    • Region Sjælland
      • Roskilde, Region Sjælland, Denmark, 4000
        • Zealand University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Understanding Danish
  • admitted to dept og oncology with diarrhea
  • cognitive intact
  • Co operable to fecal sampling

Exclusion Criteria:

  • expected survival less than 2 weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: admitted patients
fecal sampling
Device: quickfact
fecal sampling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Participants With Stool Sample Acquired
Time Frame: the sample is intended to be collected in an expected time range is within 1-2 hours after admission
instant acquiring of stool sample from acute admitted patients with diarrhea, the stool sample is collected bedside, and there after analysed with standard analysis for infectious pathogenes.
the sample is intended to be collected in an expected time range is within 1-2 hours after admission
Safety of Device
Time Frame: 5 minutes
sampling with out harm to patient
5 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Zealand University Hospital

Investigators

  • Principal Investigator: Anne-Dorte b Krapper, Oncological department, Zealand University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 26, 2021

Primary Completion (Actual)

July 2, 2024

Study Completion (Actual)

December 9, 2025

Study Registration Dates

First Submitted

May 5, 2021

First Submitted That Met QC Criteria

July 2, 2024

First Posted (Actual)

July 11, 2024

Study Record Updates

Last Update Posted (Actual)

January 30, 2026

Last Update Submitted That Met QC Criteria

January 29, 2026

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • SJ-866

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Feasibility Study

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe